Dorzolamide/timolol
From Infogalactic: the planetary knowledge core
| Combination of | |
|---|---|
| Dorzolamide | Carboanhydrase inhibitor |
| Timolol | Beta blocker |
| Clinical data | |
| Trade names | Cosopt |
| Pregnancy category |
|
| Legal status |
|
| Routes of administration |
eye drops |
| Identifiers | |
| ATC code | S01ED51 (WHO) |
| PubChem | CID: 56841571 |
| (verify) | |
Dorzolamide/timolol eyedrops (trade name Cosopt) are used for lowering pressure in the eye to normal levels, and a treatment for glaucoma. The drug is a combination of two chemicals: dorzolamide hydrochloride and timolol maleate. Both chemicals work by decreasing the production of aqueous humor. It gained Food and Drug Administration (FDA) approval in April 1998, and is supplied by Merck.
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about the eye is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a combination of chemicals
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Ophthalmology drugs
- Combination drugs
- Pharmacology stubs
- Eye stubs
